课题基金 / 基金详情

MICROPLATE SCINTILLATION/LUMINESCENCE/FLOUR COUNTER

MICROPLATE SCINTILLATION/LUMINESCENCE/FLOUR COUNTER
微孔板闪烁/发光/面粉计数器
批准号:
2503802
负责人:
THOMAS S. KUPPER
金额:
$13.36万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 1999-08-31

项目摘要

项目成果

THOMAS S. KUPPER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to establish a core facility at Brigham and Women's Hospital that would provide the laboratories of members of the user group with the capability of rapidly quantitating radioisotopic emissions, luminescence, absorption, and fluorescence from samples prepared in standard format 96 well microtiter plates. All of these capabilities would be provided by an integrated system combining a MicroBeta Trilux liquid scintillation and luminescence counter, a Tomtec 96-well plate harvester, and a Victor multilabel counter for fluorescence and photometric measurements (all components to be purchased from Wallac, Inc.). The core facility will be based in the Harvard Skin Disease Research Core Center (HSDRC) currently funded by NIAMS. The major users are primarily drawn from investigators that are currently affiliated with the HSDRC with laboratory space in the same building (Thom Research Building) in which the HSDRC laboratories are located. The major users come from the Departments of Medicine (Dermatology and Gastroenterology Divisions), and Surgery. The proposed system will incorporate features (such as multiple detectors within the counter and plate stackers) to provide rapid answers following unattended counting of microtiter plate- based assays. Interfacing of the proposed system to an existing ethernet network will allow the participating laboratories rapid and convenient access to their results. The major types of assays to be performed by members of the user group using the proposed core facility will be: (a) cell proliferation assays based on 3H-thymidine incorporation; (b) luminescent detection of luciferase as a reporter gene in transfection and transgenic mouse experiments; (c) 51Cr release assays for quantitation of cytotoxicity; (d) static adhesion assays using fluorescently labeled cells; (e) DNA quantitation by fluorometry; and (f) absorption measurements on enzyme immunoassays. Rapid and efficient counting of each of these assay types will enable users of the core facility to achieve a substantial boost in productivity and allow for timely completion of experiments. We also anticipate that the shared use of this instrumentation will provide new opportunities for interactions between investigators from the laboratories of the major users, which should in time lead to initiation of new interdisciplinary research projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
  • 批准号:
    10801033
  • 项目类别:
  • 资助金额:
    $61.87万
  • 财政年份:
    2023
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
Skin Homing T Cells
  • 批准号:
    8827484
  • 项目类别:
  • 资助金额:
    $4.41万
  • 财政年份:
    2014
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
Vaccination to generate protective tissue resident T cells
  • 批准号:
    8181512
  • 项目类别:
  • 资助金额:
    $112.4万
  • 财政年份:
    2011
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位:
Harvard Skin Disease Research Center
  • 批准号:
    7666408
  • 项目类别:
  • 资助金额:
    $66.89万
  • 财政年份:
    2010
  • 负责人:
    THOMAS S. KUPPER
  • 依托单位: